Delivery Order SPE2DX22D0069-SPE2D826F00A6
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,165.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 2, 2025, with completion expected by October 3, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contractor,...
- This delivery order, awarded on October 13, 2025, represents a $41,482.50 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC vehicle enables the company to supply a comprehensive range of...
- This delivery order, awarded on August 18, 2025, represents a $11,379.98 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This competitively awarded delivery order, with no set-aside designation, requires performance at...
- This delivery order, awarded on October 6, 2025, represents a $1,651.68 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under the company's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor...
- This delivery order, awarded October 14, 2025, represents a $81,358.70 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, with an ultimate completion date of October 15, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. As a non-set-aside award, this...
- This delivery order, awarded October 6, 2025, represents a $1,572.93 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, designated SPE2DX and extending through December 2026. The award carries no set-aside designation and was competitively...
- This delivery order, awarded on October 13, 2025, represents a $121,624.30 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Medical Supply Chain, a defense-focused federal agency. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's corporate...
- This delivery order, awarded on October 4, 2025, represents a $3,016.26 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Department's Medical Supply Chain division. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 through December 2026. This delivery order carries no set-aside designation and was competitively...
- This delivery order, awarded on October 16, 2025, represents a $135,934.08 firm fixed price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply deliveries. The contract is classified as a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award...
- This delivery order, awarded September 3, 2025, represents a $1,500.16 firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion and extending through December 2026. No set-aside designation was applied to this award, indicating it was...
- SPE2DX22D0069Indefinite Delivery Contract
- SPE2DX22D0069-SPE2D826F00A6Delivery Order
This delivery order, awarded on October 2, 2025, represents a $1.44 million firm fixed price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract, which must be completed by October 3, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support military and veteran healthcare systems. The award was competitively made with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal procurement requirements. This delivery order falls within AmerisourceBergen's broader role as a Pharmaceutical Prime Vendor supplying specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. The contract exemplifies the company's versatility in fulfilling federal medical supply needs through flexible delivery mechanisms and firm fixed pricing structures that enable efficient procurement of critical pharmaceutical inventories for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4m | 10/2/25 |